Navigation Links
Peter Zoller and Ignacio Cirac, awarded by the BBVA Foundation
Date:1/29/2009

The Basic Sciences award in this inaugural edition of the BBVA Foundation Frontiers of Knowledge Awards has been shared by physicists Peter Zoller (Austria, 1952) and Ignacio Cirac (Manresa, 1965), "for their fundamental work on quantum information science", in the words of the jury chaired by Theodor W. Hnsch, Nobel Prize in Physics. Zoller and Cirac's research is opening up vital new avenues for the development of quantum computers, immensely more powerful than those we know today.

The BBVA Foundation Frontiers of Knowledge Awards seek to recognize and encourage world-class research at international level, and can be considered second only to the Nobel Prize in their monetary amount, an annual 3.2 million euros, and the breadth of the scientific and artistic areas covered.

The awards, organized in partnership with Spain's National Research Council (CSIC), take in eight categories carrying a cash prize of 400,000 euros each. The Basic Sciences award, the sixth to be decided, is to honor contributions which significantly advance the stock of knowledge in this area for reasons of their importance and originality.

"It is a thrill to see how our expectations are being confirmed"

Peter Zoller greeted the news as "a great honor and a huge recognition for our area of work. It has been amazing to observe how this field has grown in the past ten years and how our expectations are little by little being borne out". For this investigator, sharing the prize with his one-time collaborator, Ignacio Cirac, "is an added pleasure, since a lot of this work has been done together". The Spanish researcher declared himself "especially honored because the award distinguishes the advances being made in an especially dynamic field". Cirac also chose to emphasize "the importance of basic science, which is where tomorrow's applications are born".

Peter Zoller and Ignacio Cirac are regarded as the theoretical physicists of most influence in the areas of
'/>"/>

Contact: Javier Fernandez
comunicacion@fbbva.es
34-915-376-615
Fundacin BBVA
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology technology :

1. Pacira Pharmaceuticals, Inc. Adds Experienced Physician Dr. David St. Peter to Leadership Team
2. FDAs Chief of Staff, Susan Winckler and Peter Thonis, Chief Communications
3. Caliper Life Sciences Appoints Peter F. McAree Senior Vice President and Chief Financial Officer
4. Haemonetics(R) Appoints Peter Allen as Chief Marketing Officer
5. Renowned Radiologist Peter J. Julien, MD Named Radlink Chief Medical Officer
6. Lorus Therapeutics Appoints Peter Korth as Chief Financial Officer
7. EPI-Q, Inc. Expands Capabilities with Addition of Anthony Vita, MD, MPH and Peter Herout, PharmD
8. Peter Cummings to receive the 2007 AIChE Nanoscale Science and Engineering Forum Award
9. Origin BioMed Awarded Red Herring Top 100 Global Company
10. Modigene Awarded Second-Year Grant by Israeli Government to Support Development of Its Longer-Acting Human Growth Hormone
11. Eurotech Catalyst Module Awarded to Allen Organ Company From Arrow Electronics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...re/ -- Stemline Therapeutics, Inc. today announced...targeting agents, SL-401 and SL-501, in both in v...eukemia (CML) have been selected for poster presen...American Society of Hematology (ASH), to be held i...will be presented by Stemline,s collaborators at T...
(Date:12/3/2009)...wswire/ -- Nikon Corporation, an innovator of adva...has signed a licensing agreement with Harvard Univ...stic Optical Reconstruction Microscopy (STORM) tec...ill manufacture STORM enabled microscopy systems a... Corporation President, Mr. Michio Kariya, and Nik...
(Date:12/3/2009)...wire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: S...pany, today announced a voluntary recall of five l...the Attention-Deficit/Hyperactivity Disorder (ADHD...ion because some Daytrana patches do not meet or i...val specification, and as a result, patients and c...
(Date:12/3/2009)...RNewswire-FirstCall/ -- Caliper Life Sciences, Inc...d services for drug discovery and life sciences re... for IVIS® in vivo imaging systems. Living Im... systems currently installed in laboratories world...unmixing tools to enhance fluorescent sensitivity ...
Breaking Biology Technology:Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Caliper Life Sciences Launches Living Image(R) 4.0 Software 2
...sdaq: MEDX ) announced today that it has complete...Genmab A/S which stock is traded on the,Copenhagen...n February 1,2008. Medarex expects to receive appr...m the sale. The sale of Genmab shares reduces Meda...cent., About Medarex, Medarex is a biopharmaceut...
...l,Pharmaceuticals, Inc. (Nasdaq: RIGL ) today ann...,000 shares of common stock at a price of $27.00,p...igel. The underwriters,have an option to purchase ...llotments, if any. The offering is expected to clo... of customary closing conditions., Credit Suisse ...
...ENDORSE Global Findings Highlight the Need to Urge...e VTE Management: Systematically Assess,Patient Ri...Prevent VTE, ENDORSE multinational study (Epidemi...ients at Risk for Venous Thromboembolism in the Ac...LANCET(1) demonstrates the,high prevalence of pati...
Other Biology Technology:Rigel Announces Pricing of Public Offering of Common Stock 2The LANCET Published ENDORSE, the Largest Multinational Study Showing That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE Prophylaxis 2The LANCET Published ENDORSE, the Largest Multinational Study Showing That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE Prophylaxis 3The LANCET Published ENDORSE, the Largest Multinational Study Showing That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE Prophylaxis 4
(Date:12/3/2009)... of plant and animal species can be likened to emp...inet full of potential medicines into the trash, o...rgers. , But the decline of species and their ha...earch now suggests it may also put you at greater ... destruction and biodiversity loss,"driven by the ...
(Date:12/3/2009)...Mich. (Dec. 3, 2009) Van Andel Research Institu...w the plant hormone abscisic acid (ABA) works at t...onmental stresses such as drought and cold. Their...d help engineer crops that thrive in harsh environ...tages. The findings could also have implications ...
(Date:12/3/2009)...he world when it comes to investment in energy eff...Physical Sciences Research Council (EPSRC) Chief E..."Scientific and engineering research has already b... solutions, but more investment is needed to devel...re to meet our carbon emission targets by 2020 and...
Breaking Biology News(10 mins):Species down, disease up 2Species down, disease up 3Species down, disease up 4VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Research is vital to a cleaner, greener, low carbon future 2Whistleblowers Attorney Says Pfizers Guilty Plea Today Opens New Chapter on Aggressive Enforcement of Pharma Companies 5543 1Whistleblowers Attorney Says Pfizers Guilty Plea Today Opens New Chapter on Aggressive Enforcement of Pharma Companies 5543 211 More Children Die From Swine Flu 3A CDC 59676 111 More Children Die From Swine Flu 3A CDC 59676 211 More Children Die From Swine Flu 3A CDC 59676 3Chicago Veterinary Emergency Services Goes 24 7 for Emergency Care 59672 1Chicago Veterinary Emergency Services Goes 24 7 for Emergency Care 59672 2
... A defective link in the intracellular protein "tr...acial defects, new research in zebrafish suggests....cs, Vanderbilt University Medical Center researche...uses severe skeletal deformities in zebrafish by s... , The findings are surprising, said Ela Knapik...
... A protein known to be a key component of the glue...aking them apart and promoting their movement when..., researchers at Mayo Clinic have found. , The stu...Journal of Cell Biology, helps illuminate the very... cancer that makes the disease difficult to treat,...
... Massive trauma, say from a sabertooth tiger attac... Modern man is more likely to survive severe injur... high-tech emergency medicine. Unfortunately, the ...injury that would have been fatal until recently i...echanisms in place to protect people from disease ...
Other Biology News:Cellular traffic backups implicated in skeletal malformations 2Cellular traffic backups implicated in skeletal malformations 3Two-faced protein can stop metastasis or promote it, researchers say 2Two-faced protein can stop metastasis or promote it, researchers say 3PNAS study reveals why organs fail following massive trauma 2PNAS study reveals why organs fail following massive trauma 3PNAS study reveals why organs fail following massive trauma 4PNAS study reveals why organs fail following massive trauma 5
Rabbit Anti-Human POU2F2 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Chicken Anti-HSPBP1 Polyclonal Antibody, Unconjugated from ProSci, Inc
Rabbit Anti-Human GORASP2 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
GIBCO Iscoves Modified Dulbeccos Medium (IMDM); powder from Invitrogen
Biology Products: